At a glance
- Originator Nippon Kayaku
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Candidiasis
Most Recent Events
- 16 Nov 1995 Discontinued-Preclinical for Candidiasis in Japan (Unknown route)
- 27 Jul 1995 New profile
- 27 Jul 1995 Preclinical development for Candidiasis in Japan (Intraperitoneal)